These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 31550244

  • 1. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L, Zhou D, Li J, Yan X, Zhu J, Xiao P, Chen T, Xie X.
    Med Sci Monit; 2019 Sep 24; 25():7182-7190. PubMed ID: 31550244
    [Abstract] [Full Text] [Related]

  • 2. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO, Kim MY, Cho MY, Baik SK, Cho YZ, Kwon SO.
    BMC Gastroenterol; 2014 Nov 25; 14():198. PubMed ID: 25425284
    [Abstract] [Full Text] [Related]

  • 3. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
    Jang YO, Cho MY, Yun CO, Baik SK, Park KS, Cha SK, Chang SJ, Kim MY, Lim YL, Kwon SO.
    Stem Cells Transl Med; 2016 Sep 25; 5(9):1247-56. PubMed ID: 27365486
    [Abstract] [Full Text] [Related]

  • 4. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK, Sayyed HG, Osama A, Sabry D.
    Cell Physiol Biochem; 2018 Sep 25; 48(5):2161-2171. PubMed ID: 30114694
    [Abstract] [Full Text] [Related]

  • 5. AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats.
    Fathy M, Okabe M, Saad Eldien HM, Yoshida T.
    Molecules; 2020 Jan 15; 25(2):. PubMed ID: 31952158
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
    Shao CH, Chen SL, Dong TF, Chai H, Yu Y, Deng L, Wang Y, Cheng F.
    J Surg Res; 2014 Jan 15; 186(1):408-16. PubMed ID: 24071025
    [Abstract] [Full Text] [Related]

  • 7. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M, Singh G, Fakharuzi NA, Siddikuzzaman, Balasubramanian S, Swamynathan P, Thej C, Sasidharan G, Gupta PK, Das AK, Rahman AZA, Fakiruddin KS, Nian LM, Zakaria Z, Majumdar AS.
    Stem Cell Res Ther; 2017 Jun 13; 8(1):143. PubMed ID: 28610623
    [Abstract] [Full Text] [Related]

  • 8. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver.
    Slautin V, Konyshev K, Gavrilov I, Beresneva O, Maklakova I, Grebnev D.
    Curr Stem Cell Res Ther; 2024 Jun 13; 19(11):1484-1496. PubMed ID: 38204245
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
    Mazhari S, Gitiara A, Baghaei K, Hatami B, Rad RE, Asadirad A, Joharchi K, Tokhanbigli S, Hashemi SM, Łos MJ, Aghdaei HA, Zali MR, Ghavami S.
    Eur J Pharmacol; 2020 Sep 05; 882():173263. PubMed ID: 32535098
    [Abstract] [Full Text] [Related]

  • 10. Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats.
    De Luna-Saldivar MM, Marino-Martinez IA, Franco-Molina MA, Rivera-Morales LG, Alarcón-Galván G, Cordero-Pérez P, Rojas-Martínez A, Rodríguez-Padilla C, Muñoz-Espinosa LE.
    Ann Hepatol; 2019 Sep 05; 18(4):620-626. PubMed ID: 31147180
    [Abstract] [Full Text] [Related]

  • 11. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.
    Xuan J, Feng W, An ZT, Yang J, Xu HB, Li J, Zhao ZF, Wen W.
    Mol Cell Biochem; 2017 May 05; 429(1-2):113-122. PubMed ID: 28181132
    [Abstract] [Full Text] [Related]

  • 12. Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.
    Zhou YN, Sun MY, Mu YP, Yang T, Ning BB, Ren S, Chen JM, Liu P.
    J Ethnopharmacol; 2014 May 14; 153(3):659-66. PubMed ID: 24637190
    [Abstract] [Full Text] [Related]

  • 13. [Effects of Anluohuaxianwan on transforming growth factor-β1 and related signaling pathways in rats with carbon tetrachloride-induced liver fibrosis].
    Lu W, Gao YH, Wang ZZ, Cai YS, Yang YQ, Miao YQ, Pei F, Liu XE, Zhuang H.
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr 20; 25(4):257-262. PubMed ID: 28494543
    [Abstract] [Full Text] [Related]

  • 14. JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats.
    Song SL, Gong ZJ, Huang YQ, Zhang QR, Huang TX.
    Am J Chin Med; 2006 Apr 20; 34(6):1047-61. PubMed ID: 17163593
    [Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, Baharvand H.
    Cell Biol Int; 2010 Apr 27; 34(6):601-5. PubMed ID: 20178458
    [Abstract] [Full Text] [Related]

  • 16. Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes.
    Luo XY, Meng XJ, Cao DC, Wang W, Zhou K, Li L, Guo M, Wang P.
    Stem Cell Res Ther; 2019 Jan 11; 10(1):16. PubMed ID: 30635047
    [Abstract] [Full Text] [Related]

  • 17. [Effect of forsythiaside A against CCl_4-induced liver fibrosis in mice and its mechanism].
    Guo Q, Zhang Y, Huang ZL, Lu B, Ji LL.
    Zhongguo Zhong Yao Za Zhi; 2022 Nov 11; 47(22):6137-6145. PubMed ID: 36471938
    [Abstract] [Full Text] [Related]

  • 18. Contribution and Mobilization of Mesenchymal Stem Cells in a mouse model of carbon tetrachloride-induced liver fibrosis.
    Liu Y, Yang X, Jing Y, Zhang S, Zong C, Jiang J, Sun K, Li R, Gao L, Zhao X, Wu D, Shi Y, Han Z, Wei L.
    Sci Rep; 2015 Dec 08; 5():17762. PubMed ID: 26643997
    [Abstract] [Full Text] [Related]

  • 19. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
    Su DN, Wu SP, Xu SZ.
    Stem Cell Res Ther; 2020 Sep 14; 11(1):395. PubMed ID: 32928296
    [Abstract] [Full Text] [Related]

  • 20. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM, Atta HM, Sadik NA, Azzam M.
    Cell Biochem Biophys; 2014 Jan 14; 68(1):111-25. PubMed ID: 23807535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.